
Artificial Intelligence (AI) is transforming the pharmaceutical industry by reshaping drug discovery, clinical trials, and manufacturing processes. Leveraging vast amounts of biological, chemical, and patient data, AI addresses the complexity and costs associated with traditional drug development methods. This change accelerates innovation, reduces costs, enhances clinical trials, and drives precision in medicine, altering the landscape of how treatments are developed